Development of Nanoemulsions to Enhance the Antileishmanial Activity of<i> Copaifera paupera</i> Oleoresins

Rodrigues, Igor A.; Ramos, Aline de S.; Falcão, Deborah Q.; Ferreira, José Luiz P.; Basso, Silvia L.; Silva, Jefferson Rocha de A.; Amaral, Ana Claudia F.

doi:https://doi.org/10.1155/2018/9781724

BioMed Research International

On this page

Abstract Introduction Methods Results and Discussion Conclusions Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2018 | Article ID 9781724 | https://doi.org/10.1155/2018/9781724

Development of Nanoemulsions to Enhance the Antileishmanial Activity of Copaifera paupera Oleoresins

Igor A. Rodrigues,¹Aline de S. Ramos,²Deborah Q. Falcão,³José Luiz P. Ferreira,^2,3Silvia L. Basso,⁴Jefferson Rocha de A. Silva,⁵and Ana Claudia F. Amaral²

Academic Editor: Manish K. Chourasia

Received29 Oct 2017

Revised10 Jan 2018

Accepted20 Feb 2018

Published04 Apr 2018

Abstract

Based on the ethnopharmacological evidences about the antileishmanial activity of Copaifera spp. oleoresins, the effects of crude extracts and fractions of oleoresin of two specimens from Copaifera paupera were evaluated on Leishmania amazonensis and Leishmania infantum strains. The oleoresin rich in α-copaene (38.8%) exhibited the best activity against L. amazonensis (IC₅₀ = 62.5 μg/mL) and against L. infantum (IC₅₀ = 65.9 μg/mL). The sesquiterpene α-copaene isolated was tested alone and exhibited high antileishmanial activity in vitro with IC₅₀ values for L. amazonensis and L. infantum of 17.2 and 11.4 μg/mL, respectively. In order to increase antileishmanial activity, nanoemulsions containing copaiba oleoresin and α-copaene were developed and assayed against L. amazonensis and L. infantum promastigotes. The nanoemulsion containing α-copaene (NANOCOPAEN) showed the best activity against both species, with IC₅₀ of 2.5 and 2.2 μg/mL, respectively. This is the first report about the antileishmanial activity of α-copaene.

1. Introduction

The Copaifera genus is characterized by shrubs or trees up to 40 meters high and sources of wood for the production of furniture and oleoresin (copaiba oil), extracted from its trunk, which has industrial applications. Species of Copaifera genus are mainly distributed in tropical America, with about 40 species, but are also present in tropical Africa with 4 species and in Asia, with 1 species, Copaifera palustris (Symington) De Wit, which is found in Malaysia [1, 2]. Popularly, the copaiba oil is used as anti-inflammatory and bactericidal. Some ethnopharmacological studies have suggested that Copaifera spp. oleoresins have antileishmanial activity [3–5].

Leishmaniasis is an endemic infectious disease in dozens of countries, including Brazil. The disease is caused by protozoa of the genus Leishmania (family Trypanosomatidae), whose vector is the female phlebotomine sandfly. There are three types of clinical manifestations: cutaneous, mucocutaneous, and visceral forms. The cutaneous form is the most common, frequently caused by Leishmania major and Leishmania tropica in Europe, Middle East, and Africa and by Leishmania braziliensis and Leishmania mexicana in Mexico, Central America, and South America [6]. Visceral leishmaniasis is frequently related to Leishmania donovani [7].

Conventional treatments with Glucantime, Pentostam, and Pentamidine are frequently ineffective [6]. Medicinal plants are important sources of new drugs and various studies have approached the incessant search for new therapeutic targets. Amaral et al. [8] described the effects of α-turmerone-rich hexane fraction from Curcuma longa against L. amazonensis promastigote forms. In that study, the entrapment of this hexane fraction into liposome lowered MIC values from 125 to 5.5 μg/mL. Studies evaluating the antileishmanial activity of the labdane diterpenoid andrographolide and its nanoformulations were also reported. The free form of this diterpenoid was able to inhibit the intracellular amastigotes of L. donovani at IC₅₀ values of 160 and 141 μM, respectively. After andrographolide loading into nanoparticles (formulation prepared with 4% PVA), the antileishmanial activity was significantly improved when compared with the free drug (IC₅₀ = 36 μM) [9].

In literature, there is little information on the relationship between chemical composition of Copaifera spp. oleoresins and their biological activities. The chemical composition varies according to species of Copaifera, region of collection, and specimens, which makes it difficult to identify the substance responsible for the activity. In vivo assays employing mice infected with Leishmania amazonensis suggested that the oral treatment with Copaifera martii oleoresin causes reduction in the lesions, but the mechanism of action is still unclear [10]. Tincusi et al. [11] isolated sixteen compounds of the C. paupera oil and tested ten of them against Leishmania tropica promastigote forms. Despite the traditional use as antimicrobial, the authors verified that the pure substances [(−)-copalic acid, (−)-methyl copalate, agathic acid 15-methyl ester, (−)-polyalthic acid, (−)-methyl polyalthate, (−)-pinifolic acid, (−)-methyl-18-hydroxy-copaiferolate, (−)-kaurenoic acid, and 16β-kauran-19-oic acid] had no activity in the tests and concluded that it was still not possible to predict the antileishmanial activity of that copaiba oil.

The use of nanotechnology to develop formulations with applications in human health is getting popular among researchers looking for promising alternative for the treatment of various diseases. Regarding the use of products derived from plant raw materials, especially those containing essential oils in its composition, the nanoparticles are efficient in solving problems related to their physicochemical properties. They increase the stability of these oils when exposed to high temperatures, oxidation by atmospheric oxygen, and electromagnetic radiation, thus decreasing losses due to evaporation and decomposition of the active constituents. It is believed that the nanoemulsions (fine water in oil dispersions) have antimicrobial properties due to the small size of the oil particles with high surface tension. These characteristics can damage cell membranes of microorganisms causing a synergistic effect with the active components in the formulation and thus allowing the reduction of the content of substances that cause undesirable side effects [12].

Stable emulsions, especially where synthetic surfactants are used, are best formulated with emulsifiers or combination of emulsifiers having hydrophile-lipophile balance (HLB) values close to that required of the oil phase [13]. The HLB number is a semiempirical scale for selecting surfactants [14]. Because knowledge of the emulsification properties of different surfactants is of paramount importance in the industry of emulsions, the determination of these properties (such as HLB) in new possible emulsifiers is highly desirable [15]. In the same way, the determination of required HLB value of the oil phase appears as a critical step for development of emulsions and other semisolid formulations. In addition, the number of experiments can be reduced early during the formulation screening stage by using these parameters [16].

Nanoemulsions are dispersions of droplet size usually in the range 20–200 nm. It is obtained by the high energy emulsification methods, such as high-shear stirring, high-pressure homogenizers, and ultrasound generators. Due to their characteristic size, it possesses stability against sedimentation, creaming, flocculation, or coalescence. This long-term physical stability of nanoemulsions makes them unique, and they are sometimes referred to as “approaching thermodynamic stability” [17, 18]. Nanoformulations are being developed to improve the therapeutic arsenal on neglected diseases that affect populations in developing countries, such as leishmaniasis, malaria, and Chagas disease [19–24]. Formulations based on nanotechnology can increase the antileishmanial activity of flavonoid [25], diterpene [26, 27], saponine [28], and secoiridoid derivatives [29]. Physicochemical parameters for nanoemulsions containing crude Copaifera multijuga oleoresins with high content of β-caryophyllene were developed [30].

In this context, the aim of this work was to develop nanoemulsions containing Copaifera paupera (Herzog) Dwyer oleoresin crude extract, fraction, and its main compound. Additionally, the activity of these crude extracts, fraction, main compound, and their formulations was tested on L. amazonensis and L. infantum promastigote forms.

2. Material and Methods

2.1. Plant Material

The copaiba oleoresins (RE04 and RB13) of two specimens (trees E04 and B13) from Reserva Chico Mendes, Acre State/Brazil, were identified as Copaifera paupera, codified as E04 and B13. Voucher specimen was deposited at the Herbarium of Goeldi Museum/Pará State (Number 35,524).

2.2. Chemicals

Sorbitan oleate (Span 80®) and Polysorbate 20 (Tween 20®) were purchased from La Belle Ativos Ltda (Paraná, Brazil). Kaurenoic acid was purchased from Sigma-Aldrich (USA) and -alkane standard (C7–C30) from Supelco (Bellefonte, PA, USA).

2.3. Isolation of α-Copaene

Copaiba oleoresin RE04 was submitted to preparative thin-layer chromatograph for the isolation of α-copaene. Aliquots containing 40 mg of the oleoresin were applied to aluminum sheets covered by the stationary phase silica gel 60 and eluted with hexane/ethyl acetate (7 : 3). The sesquiterpene was compared to authentic sample and confirmed by spectrometric and spectroscopic methods. 8 mg of α-copaene was obtained.

2.4. Fraction Rich in Kaurene (DIT B13)

The crude copaiba oleoresin of B13 specimen (3 g) was heated in three cycles of 40 minutes in microwave oven at medium power with intervals of 20 min for 3 hours. This procedure furnished 2.4 g of a fraction rich in kaurene diterpene (DIT B13) identified by GC-MS.

2.5. Gas-Chromatography: Mass Spectrometry (GC-MS) Analysis

Samples were analyzed and identified by GC-MS on an Agilent 6890 N GC coupled to a quadrupolar mass spectrometer (Agilent 5973N), with ionization by electronic impact (70 eV). The apparatus was fitted with a DB-5MS column (30 m × 0.25 mm I.D., 0.25 μm phase film). The injector temperature was 290°C, ion source was 230°C, and the scan-range was 40–700 m/z. The column temperature varied from 70°C to 310°C, at a rate of 5°C/min. Helium was the carrier gas at initial flow rate of 0.5 mL/min. The injected volume was 1 μL, in split rate of 10 : 1. Interpretation and identification of the fragmentation mass spectrum were carried out by comparison with the Wiley NBS mass spectrum database of the GC-MS equipment. The retention indices of constituents were calculated using the equation of van Den Dool and Kratz [31], normalized to the retention times of -alkane homologous series and compared with literature [32]. Results were expressed as relative percentage of peak area in chromatogram.

2.6. Quantification by GC-FID Analysis

Samples were analyzed by gas chromatography (Agilent 6890N GC) equipped with a flame ionization detector (GC-FID). All analyses were performed in five replicates and injected volume was 1 μL, in splitless injection. The apparatus was fitted with a DB-5 column (30 m × 0.25 mm ID, 0.25 μm phase film). The injector temperature was 290°C and the column temperature varied from 70°C to 310°C, at a rate of 5°C/min. The detector temperature was 300°C. Nitrogen was the carrier gas at initial flow rate 0.5 mL/min. Quantifications were performed by external standardization. Standard curves were constructed with five levels of analysis, ranging from 0.02375 to 0.76 mg/mL of α-copaene diluted in methanol.

2.7. Leishmania Culture

Leishmania amazonensis (IFLA/BR/1967/PH8) and L. infantum (MHOM/BR/1974/PP75) promastigote forms were obtained from the Leishmania Type Culture Collection of Oswaldo Cruz Institute/Fiocruz (Rio de Janeiro/RJ/Brazil). The parasites were maintained by weekly transfers in PBHIL medium supplemented with 10% fetal bovine serum (FBS), at 26°C [33].

2.8. Antileishmanial Activity and Inhibitory Concentrations Evaluation

Promastigote forms of L. amazonensis and L. infantum were harvested after 120 h culture (early stationary phase), washed twice with phosphate buffer saline (150 mM NaCl; 20 mM phosphate buffer, PBS, pH 7.2), and resuspended at the concentration of 5.0 × 10⁶ parasites/mL. Then 100 μL of the cellular suspension was added to 96-well microtiter plates containing different concentrations of copaiba oleoresins (RE04 and RB13), DITB13 fraction, α-copaene, or their nanoformulations, leading to final test concentrations ranging from 1 to 500 g/mL. The microtiter plates were incubated at 26°C for 120 hours in order to evaluate parasites growth inhibition. Negative controls for each sample were made by treating parasites with the highest concentration of DMSO or empty nanoemulsions used in this study. After the incubation period, L. amazonensis and L. infantum cultures were subjected to the microplate technique based on the reduction of resazurin as previously described [34]. The 50% inhibitory concentration (IC₅₀) was calculated by regression analysis using Microsoft Excel 2013. Assays were performed in triplicate () and the IC₅₀ values were expressed as μg/mL ± standard error. Statistical analysis of the differences between IC₅₀ values obtained for oleoresin or fraction samples and their respective nanoformulations were evaluated by Student’s -test. The differences were considered statistically significant whether .

2.9. Nanoemulsions Production

2.9.1. Evaluation of Required HLB Value from Copaiba Oleoresin

The required HLB value from copaiba oil was determined as described by Fernandes et al. [35]. Emulsions were prepared at a final mass of 25 g, containing 85% (w/w) of distilled water, 10% (w/w) of copaiba oil, and the emulsifiers (Tween 20 and Span 80) at total blend concentration of 5% (w/w). The required amounts of Tween 20 and Span 80 were dissolved in the oil phase. The oil and aqueous phases were heated to 75 ± 5°C, separately, and mixed by the inversion method with mechanical stirring (400 rpm) for 20 min. Series of emulsions with HLB values ranging from 4.3 to 16.7 were prepared by blending together the emulsifiers in different ratios. A second set of emulsions was later prepared using smaller ratio intervals between the two most stable emulsions from the first series.

2.9.2. Preparation of Nanoemulsion

Four nanoemulsions were developed employing as the oil phase five different samples: two samples of oleoresin crude extract from the different specimens of C. paupera (NANORE04 and NANORB13), a fraction rich in the diterpene kaurene from B13 (NANODIT B13), and α-copaene (NANOCOPAEN). Formulations were prepared at a final mass of 10 g, containing 96.25% (w/w) of distilled water, 2.5% (w/w) of oil, and Tween 20 and Span 80 (1 : 0.16) at total blend concentration of 1.25% (w/w). The emulsifiers were dissolved in the oil phase. The aqueous phase was added dropwise into the oil phase under ultrasonic homogenization (Omini Sonic Ruptor 250™, Omni Inc.) at 100 W for 6 min. A blank emulsion was prepared as described without loading the oil. Nanoemulsions obtained were stored at room temperature and characterized as the droplet size distribution and Zeta potential by dynamic light scattering (DLS) using a Zeta Potential Analyzer (ZetaPlus™, Brookhaven Inst. Corp.). Each emulsion was diluted using ultrapure Milli-Q water (1 : 25). The analyses were performed in quintuplicate. The average droplet size was expressed as the mean diameter. Following the particle size analyses of the samples, the electrode was placed inside the cuvette, and five measurements of the Zeta potential were recorded.

2.9.3. Nanoemulsions Evaluation by Transmission Electron Microscopy (TEM)

The morphology of α-copaene-loaded nanoemulsion was observed using a FEI Morgagni F 268 (Eindhoven, The Netherlands) transmission electron microscope. Samples were previously diluted in distillated water (1 : 20), filtered through 0.45 μm membrane, and placed on copper grids. The dried grids were scanned at an accelerating voltage of 80 kV.

3. Results and Discussion

Table 1 presents the list of compounds identified in the C. paupera oleoresin samples of E04 and B13. The main differences observed among the oleoresins samples were the concentrations of the sesquiterpenes α-copaene (21.8% in RB13 and 38.8% in RE04), trans-caryophyllene (4.1% in RB13 and 21.4% in RE04), δ-cadinene (7.7% in RE04), caryophyllene oxide (12.5% in RB13), and the diterpene kaurene (33.2% in RB13 and 2.4% in RE04).

In general, the chemical composition of the copaiba oleoresin is quite variable among species of Copaifera genus as well as among individuals of the same species. A great seasonal variation has been often reported, which can influence the pharmacological activity [36–39]. Sesquiterpenes and diterpenes predominate copaiba oils, and abundance of β-caryophyllene is often related [36, 37, 40–42]. The amount of β-caryophyllene in the oleoresins of Copaifera can vary from 0.7% to 62.6% in C. reticulata [37] and from 5% to 60% in C. multijuga [36]. The main sesquiterpenes content of the oleoresin collected of C. paupera specimen from Tarauacá (Acre, Brazil) were β-bisabolene (20.2%) and α-zingiberene (19.4%), and the main diterpenes were kaurenoic acid (13.3%) and copalic acid (6.1%) [41].

In our work, the α-copaene content was higher than 20%, a significant difference compared to the oleoresins of other Copaifera species whose concentrations were usually detected below 6% [37, 43–45]. Only a study with two oleoresins collected in Xapuri (Acre, Brazil) showed α-copaene as main constituent [38].

The diterpene kaurene may be present in the oil of Copaifera genus, but not so frequently. The substance can be found in the oils of root wood, root bark, trunk wood, and trunk bark of a specimen of C. langsdorffii collected in Ceará (Brazil) achieving 30.2% of the trunk wood oil [40]. Kaurene was also found in the oil obtained by hydrodistillation of some specimens of C. langsdorffii collected in Lavras (Minas Gerais State, Brazil). The highest content achieved was 4.4% of the seed oil [46]. Gelmini et al. [44] also detected this diterpene in the oleoresin from Copaifera langsdorffii. The content was 1.57% determined by GC-MS analyses. From these data it is possible to conclude that the high content of kaurene (33.2%) in the oleoresin obtained from B13 in this work differs from the great majority of Copaiba oils studied.

After the chemical characterization of RE04 and RB13 crude oleoresins, in vitro assays against L. amazonensis and L. infantum promastigotes were performed and the 50% inhibitory concentrations (IC₅₀) were determined for each sample (Table 2). Among the tested crude extracts, the copaiba RE04 oleoresin, rich in α-copaene, showed the best activity against L. amazonensis (IC₅₀ = 62.5 μg/mL) and against L. infantum (IC₅₀ = 65.9 μg/mL). Santos et al. [41] tested the antileishmanial activity of eight oils from different Copaifera spp.: C. reticulata (β-caryophyllene, α-copaene, and bergamotene), C. martii (kovalenic acid, bisabolene), C. cearensis (β-caryophyllene, α-copaene), C. paupera (bisabolene, zingiberene), C. langsdorffii (kaurenoic acid, β-caryophyllene), C. officinalis (hardwickiic acid, copalic acid), C. multijuga (β-caryophyllene, copalic acid), and C. lucens (polyalthic acid, copalic acid). The authors showed that all oleoresin samples were active against L. amazonensis promastigotes, with IC₅₀ varying from 5.0 μg/mL (C. reticulata from Pará State, Brazil) to 22.0 μg/mL (C. reticulata from Acre State, Brazil) [47].

Despite the evidences of the antileishmanial activity of Copaifera spp. oleoresins it seems that it may depend on the crude extract composition. The total sesquiterpene and diterpene contents varied from species and region of collection. This variation could explain the large differences found on the Copaifera species antileishmanial activity observed to the exudates in the present work with others reported in literature.

The main sesquiterpene of our oleoresin, α-copaene, was not tested before and demonstrated an antileishmanial activity with IC₅₀ values for L. amazonensis and L. infantum of 17.2 and 11.4 μg/mL, respectively. So, α-copaene is an important constituent of the copaiba oil with accentuated antileishmanial activity in vitro. As far as we know, this is the first report about the antileishmanial activity of α-copaene.

Diterpene acids (agathic acid, hydroxycopalic acid, kaurenoic acid, methyl copalate, pinifolic acid, and polyaltic acid) recently isolated from Copaifera oleoresins exhibited moderate to high activity against promastigote and amastigote forms of L. amazonensis [48]. Hydroxycopalic acid exhibited the highest activity against promastigotes, with IC₅₀ of 2.5 μg/mL. Kaurenoic acid and pinifolic acid showed IC₅₀ of 3.5 μg/mL and 4.0 μg/mL, respectively. These findings evidenced that diterpenes of copaiba oils should be better investigated. During the preparation of this sample RB13 in the microwave it was observed that heating the resin for more than three hours produced a brown polymer material. Thus, the time of three hours was used to obtain the fraction enriched in kaurene. The GC-MS analysis of the resulting fraction rich in kaurene (DIT B13) obtained by this alternative process is shown in Table 1. After assays, DIT B13 exhibited IC₅₀ of 167.5 and 176.0 μg/mL against L. amazonensis and L. infantum, respectively (Table 2). It is worth mentioning that this sample is rich in kaurene (64.8%). Until now, there is no study about the possible antileishmanial activity of kaurene described in literature. Overall, the sesquiterpenes found in the oleoresin, efficiently reduced by heating on microwave oven, can be associated as the most important constituents for the antileishmanial activity of copaiba oleoresins.

Contradictory antileishmaniasis activities have been attributed to the sesquiterpene β-caryophyllene. In a previous work, β-caryophyllene was tested against the promastigote and amastigote forms of L. amazonensis (MHOM/BR/77LTB0016 strain) and exhibited some activity only against the promastigote form, with IC₅₀ of 96 μM [49]. However, Soares et al. [39] reported activity against intracellular amastigotes of L. amazonensis (MHOM/BR/75/Josefa strain), with IC₅₀ of 1.3 μg/mL (6.4 μM). According to literature [49, 50], another sesquiterpene also found in the oil of B13, β-caryophyllene oxide, was not active against L. amazonensis.

Thus, the importance of leishmaniasis disease and the results obtained with the copaiba oleoresin samples motivated the search for increasing the antileishmanial activity of the samples studied using nanoemulsion formulations. Several drug delivery systems have been proposed to combat leishmaniasis. In fact, different colloidal carriers such as liposomes, niosomes, and nanoemulsions are able to deliver drugs from natural or synthetic origin to specific cellular targets. The antileishmanial activity of different phytochemicals successfully incorporated to drug delivery systems was recently reviewed [20].

First, optimized process parameters found in the preliminary study were applied as the heat temperature of the oil phase and the choice of the surfactant couple (data not shown). Different surfactants were previously tested in order to select the best couple. In this sense, the nonionic emulsifiers from fatty acid esters, Tween 20 and Span 80, showed the best results and were used at total blend of 5% w/w at different ratios to evaluate the required HLB value from copaiba oil according to the literature [35]. Stable emulsions such as nanoemulsions, especially where synthetic surfactants are used, are best formulated with emulsifiers or combination of emulsifiers having HLB (hydrophile–lipophile balance) values close to that required of the oil phase [13]. The HLB number is a semiempirical scale for selecting surfactants [14] and the determination of required HLB value of the oil phase appears as a critical step for development of emulsions and other semisolid formulations. In addition, the number of experiments can be reduced early during the formulation screening stage by using these parameters [16].

The emulsions at the lower extreme of HLB range (4.3 to 9.0) cracked right after manipulation. The emulsion formulated with HLB 15.0 was finer and showed some bluish reflection to the naked eye, known as Tyndall effect, which is characteristic for nanoemulsions. The microscopic analysis (100x) corroborates with this observation. According to the fact that minimum droplet diameter is related to the required HLB and emulsion stability, it is proposed that the most stable emulsion is the one which was formulated with the HLB of surfactants mixture nearest to required HLB of the oil phase [51, 52]. In this sense, we evaluated all emulsions until 2 months. After this period of storage, the emulsion with HLB value 15.0 showed no micro or macroscopic changes. It maintained its fine appearance and bluish reflection observed after the manipulation.

Based on this results, the nanoemulsions were formulated using the ratio of surfactants (Tween 20: Span 80, 1 : 0.16) equal to the required HLB value for the copaiba oil (15.0). Intending to avoid the heat of the oil phase, the homogenization step was realized employing high energy input by ultrasound homogenization. Ultrasonic emulsification is considered very efficient in reducing droplet size, especially for small batches [18]. The emulsions developed with both copaiba oleoresins (RE04 and RB13), the fraction rich in kaurene (DIT B13), and the sesquiterpene α-copaene employed as oil phase showed mean diameter in the range 24.5–200 nm and low polydispersity (PDI). Thus, all formulations were characterized as nanoemulsions according to Solans et al. [18]. The size distribution for all nanoemulsions is shown in Figure 1. The nanoemulsion of RB13 (NANORB13) showed the smaller droplet size. The Zeta potential showed no significant difference between the analyzed samples. The characterization results are summarized in Table 3. Figure 2 shows TEM image of NANOCOPAEN that confirmed the spherical morphology and size around 200 nm in diameter, besides the encapsulation of the bioactive sesquiterpene.

(a)

(b)

(c)

(d)

(a)

(b)

Dias et al. [30] also developed nanoemulsions containing copaiba oleoresin. In their work the formulation developed with the C. multijuga oleoresin in MTC, Tween 20, and Span 80, based on nanoemulsions using high-pressure homogenization, showed advantages over the others since it contained higher β-caryophyllene content and physical stability. In this context, the evaluated storage temperature (4°C) prevented flocculation and lower losses of volatile constituents.

In our study, nanoemulsions prepared with the crude oleoresins of C. paupera (NANORB13, NANORE04) and α-copaene (NANOCOPAEN) were assayed against L. amazonensis and L. infantum (Table 4). As expected, the nanoemulsions were able to enhance significantly the antileishmanial activity of those substances in all systems tested (). The nanoemulsion containing α-copaene (NANOCOPAEN) showed the best activity, with IC₅₀ of 2.5 and 2.2 μg/mL against L. amazonensis and L. infantum promastigote forms, respectively. Among the oleoresins, the best activity was observed with the nanoemulsion containing RE04 (NANORE04), rich in α-copaene, which showed IC₅₀ of 17.3 and 39.8 μg/mL against L. amazonensis and L. infantum, respectively. The formulation also improved the activity of DIT B13 (NANODIT B13), which exhibited IC₅₀ of 28.9 and 54.7 μg/mL against L. amazonensis and L. infantum, respectively (Table 4).

As α-copaene is abundant in all samples tested of oleoresin and demonstrated better antileishmanial activity than the crude exudates, its content in the nanoformulations was determined by GC-FID analyses. The results showed NANORE04 and NANORB13 with 0.33 and 0.13 mg/mL of α-copaene, respectively. After heating in microwave oven, α-copaene was detected at 0.04 mg/mL in the formulated kaurene-rich fraction NANODIT B13. The concentration of α-copaene incorporated into NANOCOPAEN was 1.81 mg/mL, which represents 7% of incorporation into nanoemulsion. These results are consistent with the antileishmanial activity observed in this study and with the different content of α-copaene in RE04 and RB13 oleoresins.

Taken together, these results further support the use of phytocompound nanoformulations as a promising approach for antileishmanial drugs discovery.

4. Conclusions

In conclusion, the results presented herein evidenced the in vitro antileishmanial activity of copaiba oleoresins. The sample RE04 demonstrated to be the most active oleoresin against L. amazonensis and L. infantum promastigotes and α-copaene showed better activity than the crude exudates. Additionally, RE04 and α-copaene nanoemulsions significantly increased the antileishmanial activity of these samples. This study provides contributions of new insights about the development and use of copaene as nanoemulsion and antileishmanial agent.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This research was financially supported by FAPEAM (PAPAC Program), PROEP 407856/2017-CNPq. The authors are grateful to Venício Veiga (UFRJ) for the technical support with the photomicrographies acquisition.

References

Hou Ding, “Studies in Malesian Caesalpinioideae (Leguminosae). I. The genera Acrocarpus, Afzelia, Copaifera and Intsia,” Blumea: Journal of Plant Taxonomy and Plant Geography, vol. 38, no. 2, pp. 313–330, 1994.
View at: Google Scholar
R. C. V. Martins-da-Silva, J. F. Pereira, and H. C. Lima, “O gênero Copaifera (Leguminosae – Caesalpinioideae) na Amazônia Brasileira,” Rodriguésia, vol. 59, pp. 455–476, 2008.
View at: Google Scholar
R. C. R. Moreira, J. M. M. Rebêlo, M. E. A. Gama, and J. M. L. Costa, “Awareness of American tegumentary leishmaniasis (ATL) and use of alternative therapies in an endemic area in the Amazon Region in the State of Maranhão, Brazil,” Cadernos de Saúde Pública, vol. 18, pp. 187–195, 2002.
View at: Google Scholar
L. P. Kvist, S. B. Christensen, H. B. Rasmussen, K. Mejia, and A. Gonzalez, “Identification and evaluation of Peruvian plants used to treat malaria and leishmaniasis,” Journal of Ethnopharmacology, vol. 106, no. 3, pp. 390–402, 2006.
View at: Publisher Site | Google Scholar
Y. Estevez, D. Castillo, M. T. Pisango et al., “Evaluation of the leishmanicidal activity of plants used by Peruvian Chayahuita ethnic group,” Journal of Ethnopharmacology, vol. 114, no. 2, pp. 254–259, 2007.
View at: Publisher Site | Google Scholar
T. S. Tiuman, A. O. Santos, T. Ueda-Nakamura, B. P. D. Filho, and C. V. Nakamura, “Recent advances in leishmaniasis treatment,” International Journal of Infectious Diseases, vol. 15, no. 8, pp. e525–e532, 2011.
View at: Publisher Site | Google Scholar
M. B. Jamjoom, R. W. Ashford, P. A. Bates et al., “Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and "L. archibaldi" from this region are a consequence of convergent evolution in the isoenzyme data,” Parasitology, vol. 129, no. 4, pp. 399–409, 2004.
View at: Publisher Site | Google Scholar
A. C. F. Amaral, L. A. Gomes, J. R. D. A. Silva et al., “Liposomal formulation of turmerone-rich hexane fractions from Curcuma longa enhances their antileishmanial activity,” BioMed Research International, vol. 2014, Article ID 694934, 2014.
View at: Publisher Site | Google Scholar
P. Roy, S. Das, T. Bera, S. Mondol, and A. Mukherjee, “Andrographolide nanoparticles in leishmaniasis: Characterization and in vitro evaluations,” International Journal of Nanomedicine, vol. 5, no. 1, pp. 1113–1121, 2010.
View at: Publisher Site | Google Scholar
A. O. dos Santos, M. A. Costa, T. Ueda-Nakamura et al., “Leishmania amazonensis: Effects of oral treatment with copaiba oil in mice,” Experimental Parasitology emphasizes, vol. 129, no. 2, pp. 145–151, 2011.
View at: Publisher Site | Google Scholar
B. M. Tincusi, I. A. Jiménez, I. L. Bazzocchi et al., “Antimicrobial terpenoids from the oleoresin of the Peruvian medicinal plant Copaifera paupera,” Planta Medica, vol. 68, no. 9, pp. 808–812, 2002.
View at: Publisher Site | Google Scholar
A. R. Bilia, C. Guccione, B. Isacchi, C. Righeschi, F. Firenzuoli, and M. C. Bergonzi, “Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 651593, 14 pages, 2014.
View at: Publisher Site | Google Scholar
L. O. Orafidiya and F. A. Oladimeji, “Determination of the required HLB values of some essential oils,” International Journal of Pharmaceutics, vol. 237, no. 1-2, pp. 241–249, 2002.
View at: Publisher Site | Google Scholar
W. C. Griffin, “Classification of surface-active agents by HLB,” Journal of the Society of Cosmetic Chemists, vol. 1, pp. 311–326, 1949.
View at: Google Scholar
V. Verdinelli, P. V. Messina, P. C. Schulz, and B. Vuano, “Hydrophile-lipophile balance (HLB) of n-alkane phosphonic acids and theirs salts,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 316, no. 1–3, pp. 131–135, 2008.
View at: Publisher Site | Google Scholar
T. Schmidts, D. Dobler, A.-C. Guldan, N. Paulus, and F. Runkel, “Multiple W/O/W emulsions-Using the required HLB for emulsifier evaluation,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 372, no. 1-3, pp. 48–54, 2010.
View at: Publisher Site | Google Scholar
P. Izquierdo, J. Esquena, T. H. F. Tadros et al., “Formation and stability of nano-emulsions prepared using the phase inversion temperature method,” Langmuir, vol. 18, no. 1, pp. 26–30, 2002.
View at: Publisher Site | Google Scholar
C. Solans, P. Izquierdo, J. Nolla, N. Azemar, and M. J. Garcia-Celma, “Nano-emulsions,” Current Opinion in Colloid & Interface Science , vol. 10, no. 3-4, pp. 102–110, 2005.
View at: Publisher Site | Google Scholar
C. B. Fox, “Squalene emulsions for parenteral vaccine and drug delivery,” Molecules, vol. 14, no. 9, pp. 3286–3312, 2009.
View at: Publisher Site | Google Scholar
D. Claborn, Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment, InTech, 2014.
View at: Publisher Site
K. Jain, K. Gowthamarajan, S. Sood, K. Elango, and B. Suresh, “Olfactory drug delivery of artemether-curcumin combination for management of cerebral malaria,” Malaria Journal, vol. 11, no. Suppl 1, p. P51, 2012.
View at: Publisher Site | Google Scholar
K. Jain, S. Sood, and K. Gowthamarajan, “Modulation of cerebral malaria by curcumin as an adjunctive therapy,” The Brazilian Journal of Infectious Diseases, vol. 17, no. 5, pp. 579–591, 2013.
View at: Publisher Site | Google Scholar
P. K. Gupta, A. K. Jaiswal, S. Asthana et al., “Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: An approach for non-toxic chemotherapy,” British Journal of Pharmacology, vol. 172, no. 14, pp. 3596–3610, 2015.
View at: Publisher Site | Google Scholar
L. G. Lucca, S. P. de Matos, B. T. Borille et al., “Determination of β-caryophyllene skin permeation/retention from crude copaiba oil (Copaifera multijuga Hayne) and respective oil-based nanoemulsion using a novel HS-GC/MS method,” Journal of Pharmaceutical and Biomedical Analysis, vol. 104, pp. 144–148, 2015.
View at: Publisher Site | Google Scholar
S. Sarkar, S. Mandal, J. Sinha, S. Mukhopadhyay, N. Das, and M. K. Basu, “Quercetin: Critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes,” Journal of Drug Targeting, vol. 10, no. 8, pp. 573–578, 2002.
View at: Publisher Site | Google Scholar
S. Lala, A. K. Nandy, S. B. Mahato, and M. K. Basu, “Delivery in vivo of 14-deoxy-11-oxoandrographolide, an antileishmanial agent, by different drug carriers,” Indian Journal of Biochemistry and Biophysics, vol. 40, no. 3, pp. 169–174, 2003.
View at: Google Scholar
J. Vasir, M. Reddy, and V. Labhasetwar, “Nanosystems in Drug Targeting: Opportunities and Challenges,” Current Molecular Pharmacology, vol. 1, no. 1, pp. 47–64, 2005.
View at: Publisher Site | Google Scholar
J. Sinha, B. Raay, N. Das et al., “Bacopasaponin C: Critical evaluation of anti-leishmanial properties in various delivery modes,” Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, vol. 9, no. 1, pp. 55–62, 2002.
View at: Publisher Site | Google Scholar
S. Medda, S. Mukhopadhyay, and M. K. Basu, “Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms,” Journal of Antimicrobial Chemotherapy, vol. 44, no. 6, pp. 791–794, 1999.
View at: Publisher Site | Google Scholar
D. O. Dias, M. Colombo, R. G. Kelmann et al., “Optimization of Copaiba oil-based nanoemulsions obtained by different preparation methods,” Industrial Crops and Products, vol. 59, pp. 154–162, 2014.
View at: Publisher Site | Google Scholar
H. van Den Dool and P. D. Kratz, “A generalization of the retention index system including linear temperature programmed gas—liquid partition chromatography,” Journal of Chromatography A, vol. 11, pp. 463–471, 1963.
View at: Publisher Site | Google Scholar
R. P. Adams, Identification of Essential Oil Components by Gas Chromatography/Quadrupole Mass Spectrometry, Allured Publishing Corp, Carol Stream, IL, USA, 2007.
I. de Almeida Rodrigues, B. Alcântara da Silva, A. L. Souza dos Santos et al., “Erratum: A new experimental culture medium for cultivation of Leishmania amazonensis: Its efficacy for the continuous in vitro growth and differentiation of infective promastigote forms (Parasitol Res (DOI 10.1007/s00436-010-1775-4)),” Parasitology Research, vol. 107, no. 1, p. 249, 2010.
View at: Publisher Site | Google Scholar
M. Rolón, C. Vega, J. A. Escario, and A. Gómez-Barrio, “Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes,” Parasitology Research, vol. 99, no. 2, pp. 103–107, 2006.
View at: Publisher Site | Google Scholar
C. P. Fernandes, M. P. Mascarenhas, F. M. Zibetti et al., “HLB value, an important parameter for the development of essential oil phytopharmaceuticals,” Revista Brasileira de Farmacognosia, vol. 23, no. 1, pp. 108–114, 2013.
View at: Publisher Site | Google Scholar
P. C. Souza Barbosa, L. S. Moreira Wiedemann, R. Da Silva Medeiros, P. De Tarso Barbosa Sampaio, G. Vieira, and V. Florêncio Da Veiga-Junior, “Phytochemical fingerprints of copaiba oils (Copaifera multijuga Hayne) determined by multivariate analysis,” Chemistry & Biodiversity, vol. 10, no. 7, pp. 1350–1360, 2013.
View at: Publisher Site | Google Scholar
C. Herrero-Jáuregui, M. A. Casado, M. das Graças Bichara Zoghbi, and R. Célia Martins-da-Silva, “Chemical variability of Copaifera reticulata ducke oleoresin,” Chemistry & Biodiversity, vol. 8, no. 4, pp. 674–685, 2011.
View at: Publisher Site | Google Scholar
M. D. G. B. Zoghbi, R. C. V. Martins-da-Silva, and J. R. Trigo, “Volatiles of Oleoresins of Copaifera paupera (Herzog) Dwyer C. piresii Dwyer and C. pubiflora Benth. (Leguminosae),” Journal of Essential Oil Research, vol. 21, no. 5, pp. 403-404, 2009.
View at: Publisher Site | Google Scholar
D. C. Soares, N. A. Portella, M. F. D. S. Ramos, A. C. Siani, and E. M. Saraiva, “Trans-β-caryophyllene: An effective antileishmanial compound found in commercial copaiba Oil (Copaifera spp.),” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 761323, 2013.
View at: Publisher Site | Google Scholar
N. V. Gramosa and E. R. Silveira, “Volatile constituents of Copaifera langsdorffii from the brazilian northeast,” Journal of Essential Oil Research, vol. 17, no. 2, pp. 130–132, 2005.
View at: Publisher Site | Google Scholar
A. O. Santos, T. Ueda-Nakamura, B. P. D. Filho, V. F. V. Junior, A. C. Pinto, and C. V. Nakamura, “Effect of Brazilian copaiba oils on Leishmania amazonensis,” Journal of Ethnopharmacology, vol. 120, no. 2, pp. 204–208, 2008.
View at: Publisher Site | Google Scholar
L. M. Leandro, F. de Sousa Vargas, P. C. Barbosa, J. K. Neves, J. A. da Silva, and V. F. da Veiga-Junior, “Chemistry and Biological Activities of Terpenoids from Copaiba (Copaifera spp.) Oleoresins,” Molecules, vol. 17, no. 12, pp. 3866–3889, 2012.
View at: Publisher Site | Google Scholar
D. D. O. Dias, M. Colombo, R. G. Kelmann et al., “Optimization of headspace solid-phase microextraction for analysis of β-caryophyllene in a nanoemulsion dosage form prepared with copaiba (Copaifera multijuga Hayne) oil,” Analytica Chimica Acta, vol. 721, pp. 79–84, 2012.
View at: Publisher Site | Google Scholar
F. Gelmini, G. Beretta, C. Anselmi et al., “GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect,” International Journal of Pharmaceutics, vol. 440, no. 2, pp. 170–178, 2013.
View at: Publisher Site | Google Scholar
V. F. Veiga Jr., L. Zunino, M. L. Patitucci, A. C. Pinto, and J. B. Calixto, “The inhibition of paw oedema formation caused by the oil of Copaifera multijuga Hayne and its fractions,” Journal of Pharmacy and Pharmacology, vol. 58, no. 10, pp. 1405–1410, 2006.
View at: Publisher Site | Google Scholar
M. E. do Nascimento, M. D. G. B. Zoghbi, J. E. Brasil Pereira Pinto, and S. K. Vilela Bertolucci, “Chemical variability of the volatiles of Copaifera langsdorffii growing wild in the Southeastern part of Brazil,” Biochemical Systematics and Ecology, vol. 43, pp. 1–6, 2012.
View at: Publisher Site | Google Scholar
A. O. dos Santos, T. Ueda-Nakamura, B. P. D. Filho, V. F. D. V. Junior, and C. V. Nakamura, “Copaiba oil: an alternative to development of new drugs against leishmaniasis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 898419, 7 pages, 2012.
View at: Publisher Site | Google Scholar
A. O. dos Santos, E. Izumi, T. Ueda-Nakamura, B. P. Dias-Filho, V. F. da Veiga-Júnior, and C. V. Nakamura, “Antileishmanial activity of diterpene acids in copaiba oil,” Memórias do Instituto Oswaldo Cruz, vol. 108, no. 1, pp. 59–64, 2013.
View at: Publisher Site | Google Scholar
D. F. M. do Carmo, A. C. F. Amaral, G. M. C. Machado, L. L. Leon, and J. R. de Andrade Silva, “Chemical and biological analyses of the essential oils and main constituents of Piper species,” Molecules, vol. 17, no. 2, pp. 1819–1829, 2012.
View at: Publisher Site | Google Scholar
V. Cascon and B. Gilbert, “Characterization of the chemical composition of oleoresins of Copaifera guianensis Desf., Copaifera duckei Dwyer and Copaifera multijuga Hayne,” Phytochemistry, vol. 55, no. 7, pp. 773–778, 2000.
View at: Publisher Site | Google Scholar
P. Prinderre, P. Piccerelle, E. Cauture, G. Kalantzis, J. P. Reynier, and J. Joachim, “Formulation and evaluation of o/w emulsions using experimental design,” International Journal of Pharmaceutics, vol. 163, no. 1-2, pp. 73–79, 1998.
View at: Publisher Site | Google Scholar
J. L. Salager, “Pharmaceutical Emulsions And Suspensions: Drugs and The Pharmaceutical Sciences,” F. Nielloud and G. MartiI-Mestres, Eds., pp. 19–72, Marcel Dekker, New York, NY, USA, 2000.
View at: Google Scholar

Copyright

Copyright © 2018 Igor A. Rodrigues et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2652

Downloads

1581

Citations